Moreover, in vitro studies have further indicated that IL-2 can quickly and significantly increase the PD-1+ NK cell ratios of lung cancer patients; and similar results been confirmed in NK cells from healthy donors 22. This evidence concerns the gene PDCD1 and lung carcinoma.